Pharmaceuticals & Biotech|Legal Compliance

Novo Nordisk
Regulatory document automation

Writers averaged 2.3 reports/year. Teams now generate 300-page regulatory drafts in minutes, cutting writing time by 90%.

PublishedOct 14, 2025|3 months ago

Key results

Writing Time Reduction
90%
Cycle Time Reduction
50%
Creation Time
<1 min
vs months of work

Result highlights

Unlock 4 result highlights

The story

A global pharmaceutical leader and maker of Ozempic develops medicines for chronic diseases, facing strict regulatory requirements that demand massive volumes of documentation for every new treatment.

Producing a single clinical study report was a multi-month cycle, with staff writers averaging only 2.3 reports per year while daily delays cost up...

Unlock full story

Quotes

Unlock 4 more quotes

The company

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Pharmaceutical company specializing in diabetes, obesity, and rare blood disorders.

IndustryPharmaceuticals & Biotech
LocationBagsværd, Denmark
Employees50K-100K
Founded1923

Scope & timeline

  • Prototyping time cut from weeks to hours

Explore similar

Find AI opportunities for your
business context

Understand what's working with 2,776 recent AI case studies across industries. We structure things so you can find high-impact strategies for your exact context.

Graphic placeholder

Industries covered